Results 141 to 150 of about 2,118 (199)

Incidence and clinical relevance of donor-derived recipient-specific anti-HLA antibodies in haploidentical hematopoietic stem cell transplantation: a retrospective study. [PDF]

Cell Transplant
Huang X, Ren Y, Wang S, Mei C, Xu Y, Jin J, Tong H, Qian J.   +7 more
europepmc   +1 more source

Genetics by genetic algorithm: Defining an ideal platelet donor population to support patients with HLA-mediated alloimmune refractoriness. [PDF]

Transfusion
Blake JT, Rickards N, Mack J, Seftel M, Gupta A.   +4 more
europepmc   +1 more source

Remimazolam-Based Anesthetic Management in a Patient with Severe Aortic Stenosis and Myelodysplastic Syndrome-Related Thrombocytopenia: A Case Report. [PDF]

J Clin Med
Lee SH, Cho SB, Choo H, Park J, Byun SH.
europepmc   +1 more source

Anti-HLA class I IgG subclasses skew platelet activation mechanisms in transfusion refractoriness. [PDF]

Haematologica
Couvidou A, Wald M, Angénieux C, Pires-Marafon J, Apithy MJ, Humbrecht C, Fornecker LM, Congy-Jolivet N, Dupuis A, Rollin J, Maître B.   +10 more
europepmc   +1 more source

Laboratory Assessment and Clinical Outlook for <i>Ex Vivo</i>-Produced Human Platelets and Megakaryocytes from Stem Cell Sources. [PDF]

Ann Lab Med
Kim KM, Albaira KI, Cho YG, Kim HO, Kim HJ, Kwon SS, Lee J, Ko DH, Kim S, Lee SY.   +9 more
europepmc   +1 more source

Editorial: Endothelium, innate immunity and coagulation in hematological disorders. [PDF]

Front Med (Lausanne)
Evangelidis P, Gavriilaki E.
europepmc   +1 more source

Analysis of influencing factors and predictive model construction for platelet transfusion efficacy in hematological patients. [PDF]

Front Med (Lausanne)
Zou Y, Jiang T, Fan Y, Liang S, Lin L, Zheng M.   +5 more
europepmc   +1 more source